Biological Activities and Polyphenol Content of Qi Cha Tea®, a Functional Beverage of White Tea Containing Botanicals and Dry Botanical Extracts with European Health Claims.

Infusions of Camellia sinensis leaves have been known for their health benefits. The Bio Concentrate Assets® (ABC) method is a method of enriching organic infusion leaves (from Camellia sinensis) with organic dry and concentrated extracts using organic acacia gum, and its application to white tea has provided Qi cha tea®. In the present study, the content of tea polyphenols and caffeine, and the biochemical properties of Qi cha tea® and its botanical constituents (elderberry, tulsi, Echinacea purpurea, orange peel, lemongrass, and acacia gum) were assessed. Antioxidant and cell viability activities were determined by the 1,1-diphenyl-2-picrylhydrazyl (DPPH) assay and MTT (3-(4, 5-dimethyl thiazol-2-yl)-2, 5-diphenyl tetrazolium bromide) assay in human Caco-2 and HCT-116 cell lines, and ascorbic acid and tamoxifen, respectively. The caffeine and polyphenol composition of Qi cha tea® was modified with less caffeine and gallic acid and more epigallocatechin gallate (EGCG) than the original white tea. The majority of the tested botanical samples including Qi cha tea® at 50 µg/mL show similar antioxidant activities, with the exception of Echinacea purpurea. The greatest effect was found for white tea. The antioxidant power of the Qi cha tea® (90% at 50 µg/mL for pressurized liquid extraction (PLE) was divided by approximately a factor of two (61% at 50 µg/mL for pressurized liquid extraction products (PLEP)), which corresponds to the 48.3% (mass/mass) white tea original content in the Qi cha tea®. Qi cha tea® shows the lowest cytotoxic activity in the viability of the two cell lines when compared to white tea. The application of the ABC method to Qi cha tea® using various botanicals and dry extract with acacia gum as blinder has allowed the development of a new innovative functional health beverage that complies with European health claims.

ABC, a patented innovation in the infusion of teas and herbal plants: enrichment of Camellia sinensis leaves with dry extracts from herbal plants.

Tea and herbal infusions have been known for millennia for their health benefits. However for plants and active ingredients (of mineral and animal origin), it is necessary to consume very large quantities to achieve what is called the health claim dose, i.e., the dose for which the effect on health claim is established. Camellia sinensis leaves is traditionally used as plant infusion. This article aims to review the innovation afforded by the ABC (Bio Concentrate Assets®) patent. The ABC patent has developed an exclusive method of enriching organic tea leaves with organic herbal dry plant extracts using organic acacia gum. This method allows the coupling of concentrated dry extracts from medicinal plants on the Camellia sinensis leave extracts using acacia gum (arabic gum) and to reach to low enough health claim doses thanks to a higher concentration of active ingredients (tested until 10 ingredients). An example of ABC application is provided in a brief overview of manufacturing process for the "Gingo® tea" preparation. The main advantages of the ABC patent application are discussed. In conclusion, the ABC process offers a real breakthrough in the market of teas and herbal teas for health and wellness.